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Introduction
Air pollution is associated with impaired lung 
function growth in childhood and acceler­
ated age­related lung function decline in 
adulthood (Breton et al. 2011). Mechanisms 
hypothesized to mediate the association 
include inflammatory and oxidative stress 
pathways (Andersen et al. 2011). Local as 
well as systemic inflammation is associated 
with poor lung function (Gotz et al. 2011). 
Persons exposed to inhaled particles from 
ambient air pollution develop systemic as well 
as pulmonary inflammation and have sys­
temic oxidative stress, which is characterized 
by markers in circulating blood, bronchio­
alveolar lavage, induced sputum, or exhaled 
breath (Hogg and van Eeden 2009; Sinden 
and Stockley 2010).
Various markers of obesity such as 
weight or body mass index (BMI), as well 
as measures of fat distribution such as waist 
circumference, ratio of waist circumference 
to body surface area or height, percentage 
of fat mass, and skinfold thickness, are also 
related to both spirometric lung volume and 
flow parameters, as well as to inflammation 
in both blood and lung (Salome et al. 2010). 
The mechanisms by which excess body fat 
may affect lung function can be categorized 
as mechanical and nonmechanical (Franssen 
et al. 2008; Steele et al. 2009).
The mechanical effect of abdominal obe­
sity on lung volumes and associated reduc­
tions in airway caliber is thought to be the 
predominant mode of action (Chen et al. 
2007; Salome et al. 2010). This is supported 
by the observation that the ratio of forced 
expiratory volume in 1 sec (FEV1) to forced 
vital capacity (FVC) is usually preserved or 
increased, even in cases of morbid obesity. 
Both FEV1 and FVC decrease in paral­
lel with increasing abdominal obesity, even 
after controlling for BMI (Hickson et al. 
2011). Moreover, obesity stiffens the respi­
ratory system and increases the mechanical 
work needed for breathing. This is presumed 
to be attributable to a combination of effects 
on lung and chest wall compliance (Jones 
et al. 2007).
Inflammatory pathways may also medi­
ate the influence of obesity on lung function 
(Probst­Hensch 2010). Effects of obesity on 
airway caliber and obstruction to air flow that 
were not merely explained by a mechanical 
effect on lung volume have been reported in a 
limited number of studies (e.g., Salome et al. 
2010). It is hypothesized that proinflamma­
tory adipokines produced by adipose tissue 
may contribute to airway remodeling in obese 
persons (Margretardottir et al. 2009; McClean 
et al. 2008; Tkacova 2010). Circulating 
inflammatory markers and adipokines (e.g., 
soluble tumor necrosis factor receptor 1, 
adiponectin, leptin) were inconsistently asso­
ciated with respiratory function in subjects 
with excess body weight (Lecube et al. 2011; 
Thyagarajan et al. 2010). Moreover, air pol­
lution and obesity were reported to have 
greater than additive effects on markers of 
systemic inflammation among men enrolled 
in the Normative Aging Study (Madrigano 
et al. 2009).
In light of inflammatory pathways poten­
tially shared between air pollution and obe­
sity (Chinn et al. 2006; Wise et al. 1998) 
we investigated whether the association 
between improved air quality and lung health 
is also weight dependent. In the SAPALDIA 
(Swiss Study on Air Pollution and Lung 
Disease in Adults) cohort, improvements in 
exposure to PM10 (particulate matter with 
aerodynamic diameter ≤ 10 µm) over an 
11­year follow­up period were associated 
with attenuated age­related lung function 
decline. The association was strongest for the 
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Background: Air pollution and obesity are hypothesized to contribute to accelerated decline in 
lung function with age through their inflammatory properties. 
oBjective: We investigated whether the previously reported association between improved air 
quality and lung health in the population-based SAPALDIA cohort is modified by obesity.
Methods: We used adjusted mixed-model analyses to estimate the association of average body 
mass index (BMI) and changes in particulate matter with aerodynamic diameter ≤ 10 µm (PM10; 
ΔPM10) with lung function decline over a 10-year  follow-up period.
results: Lung function data and complete information were available for 4,664 participants. Age-
related declines in lung function among participants with high average BMI were more rapid for 
FVC (forced vital capacity), but slower for FEV1/FVC (forced expiratory volume in 1 sec/FVC) and 
FEF25–75 (forced expiratory flow at 25–75%) than declines among those with low or normal average 
BMI. Improved air quality was associated with attenuated reductions in FEV1/FVC, FEF25–75, and 
FEF25–75/FVC over time among low- and normal-BMI participants, but not overweight or obese 
participants. The attenuation was most pronounced for ΔFEF25–75/FVC (30% and 22% attenua-
tion in association with a 10-µg/m3 decrease in PM10 among low- and normal-weight participants, 
respectively.)
conclusion: Our results point to the importance of considering health effects of air pollution 
exposure and obesity in parallel. Further research must address the mechanisms underlying the 
observed interaction.
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decline in forced expiratory flow at 25–75% 
(FEF25–75), an early marker of damage to the 
airways, but was also evident for FEV1 and 
FEV1/FVC (Downs et al. 2007). We now 
investigate whether these previously reported 
 attenuations were modified by BMI.
Methods
Study  popu la t ion .  SAPALDIA i s  a 
 population­based study of the long­term 
effect of air pollution on respiratory health 
in the Swiss adult population, as previously 
described in detail (Ackermann­Liebrich et al. 
1997, 2005; Downs et al. 2007; Martin et al. 
1997). Briefly, the study comprised eight 
study areas (Basel, Geneva, Davos, Aarau, 
Payenne, Montana, Wald, and Lugano) 
that represent a broad range of geography, 
climate, urbanization, and air pollution. At 
baseline in 1991, random population samples 
of persons 18–60 years of age were invited to 
participate in SAPALDIA. A total of 8,047 
of 9,651 baseline participants (response rate, 
83.4%) completed a follow­up assessment 
in 2002. Valid spirometry data from both 
surveys were available for 5,741 participants, 
of whom 4,730 had complete information 
on BMI and covariates. After excluding 
66 subjects, we restricted the present analy­
sis to 4,664 participants (see Supplemental 
Material, Figure S1).
Ethical approval was obtained from 
the central ethics committee of the Swiss 
Academy of Medical Sciences and from the 
Cantonal Ethics Committees in each of the 
eight examination areas. All study partici­
pants provided written and informed consent 
before the health examinations.
Lung function asses sment.  In the 
SAPALDIA study, lung function measure­
ments were conducted using the same spi­
rometer, software, and protocols in both 1991 
and 2002 (Sensor Medics 2200SP; Sensor 
Medics, Yorba Linda, CA, USA). The pro­
tocol for the lung function measurements 
was in accordance with American Thoracic 
Society (ATS) recommendations (ATS 1991).
Three to eight maneuvers were performed 
under direction of trained technicians, to 
comply with ATS acceptability and repro­
ducibility criteria. Lung function parameters 
used in the present analysis were the highest 
FEV1; FVC; the best peak expiratory flow 
(PEF); forced expiratory flows at 25%, 50%, 
and 75% of FVC (FEF25, FEF50, FEF75); and 
mid­expiratory flow (FEF25–75) derived from 
the best maneuver (defined as the one with 
the highest sum of FEV1 + FVC). All measur­
ing instruments were calibrated at least once a 
day. Bronchodilation was not conducted. The 
annual rate of change in lung function (Δlung 
function/years) was defined for each partici­
pant as lung function at follow­up minus 
lung function at baseline divided by years of 
follow­up, such that negative values repre­
sent a decline in the respective lung function 
parameters over time.
Assessment of individual air pollution 
exposure. Details of individual assignment of 
annually averaged home outdoor air pollution 
exposures are described elsewhere (Downs 
et al. 2007; Liu et al. 2007). As in the previ­
ous studies, concentrations of ambient PM10 
were used as markers of air pollution. Briefly, 
we used dispersion models developed by the 
Swiss Agency for Environment, Forests and 
Landscape (PolluMap, version 2.0; Swiss 
Agency for the Environment, Forests, and 
Landscape, Bern, Switzerland) to estimate 
each participant’s annual exposure to PM10 
outside the residence (Ackermann­Liebrich 
et al. 2005). Inputs for the 1990 and 2000 
PolluMap models were hourly meteorologi­
cal and pollutant emission data from differ­
ent sources, distributed over 200 × 200 m 
grid cells. The emission strengths were mod­
eled for diurnal variation, weekday–weekend 
differences, and seasonal variations. Hourly 
predictions were averaged over the year, to 
obtain annual averages for each grid cell. 
Historical trends of central­site PM10 con­
centrations were used to interpolate values 
between 1990 and 2000 and extrapolate up 
to 2003 (Liu et al. 2007). Each participant’s 
home address was geocoded and assigned to 
an annual concentration, after the address 
codes were matched with the concentration 
grid cell generated by the dispersion models. 
For the current analysis, we used the differ­
ence in the annual average PM10 exposures 
between 2002 and 1991 (ΔPM10); thus, a 
negative value indicates an improvement in 
air quality.
Assessment of obesity. Height was mea­
sured (without shoes) in the first and sec­
ond assessment. Weight was self­reported at 
baseline and measured (without shoes and 
coat) at follow­up. We used the BMI (kilo­
grams divided by meters squared) as an obe­
sity parameter. Change in BMI (ΔBMI) was 
expressed as BMI at follow­up minus BMI at 
baseline, with positive values reflecting weight 
gain during follow­up. BMI values at baseline 
and follow­up were averaged and categorized 
as underweight (BMI < 18.5), normal weight 
(BMI ≥ 18.5 to < 25), overweight (BMI ≥ 25 
to < 30), and obese (BMI ≥ 30). The average 
BMI was a priori selected over ΔBMI as a 
primary effect modifier of interest, to better 
reflect chronic long­term exposure to adipose 
tissue inflammation.
Risk factor assessment. Information on 
age, sex, smoking status, passive smoking, 
current and past occupational exposure to dust 
and fumes, level of education, and hay fever 
were obtained from self­reported question­
naire data provided at both study exami­
na tions. Educational levels were classified 
into three categories (< 10 years, 10 years, 
or > 10 years of education) and used as a 
proxy for socioeconomic status. Participants 
were classified as atopic if a wheal of at least 
3 mm diameter developed in response to 
one or more of the eight inhalant allergens 
tested by skin­prick tests at baseline in 1991 
(cat, timothy grass, parietaria, birch, house­
dust mite, Alternaria tenuis, Cladosporium 
herbarum, and dog).
Statistical analysis. To assess the modify­
ing effects of average BMI on the associa­
tion between ΔPM10 and Δlung function, we 
used covariate­adjusted mixed linear models 
as developed previously for assessing the effect 
of improved air quality (Downs et al. 2007). 
The annual rate of decline in lung function 
was regressed on ΔPM10 and average BMI. 
The adjusted models included the following 
covariates: ΔBMI, square of average BMI, 
baseline PM10, age, age squared, sex, height, 
smoking status at baseline (never, former, 
current), pack­years smoked up to and since 
baseline, cigarettes smoked per day at baseline 
and follow­up, passive smoking in childhood, 
level of education at baseline and change of 
education, nationality (Swiss or other), pres­
ence or absence of occupational exposure to 
dust or fumes at both examinations, presence 
or absence of atopy, and seasonal effects (sine 
and cosine function of day of examination) at 
both examinations. The models were further 
adjusted for residual clustering within areas 
using a random intercept.
Estimated independent associations (and 
their 95% CIs) of longitudinal changes in 
lung function parameters with changes in 
PM10 exposure and with average BMI were 
derived from regression models that included 
interaction terms between air pollution and 
average BMI. The hypothesis of average BMI 
modifying the ΔPM10 effect was tested using 
an interaction term between these two param­
eters. BMI category–specific effect estimates 
for ΔPM10 were derived from four differ­
ent models, in which BMI was alternatively 
centered at each of the mean values of the 
four BMI categories. Sixty­six observations 
with a Cook’s distance above the 99.5th per­
centile in at least one of the basic models for 
the different lung function parameters were 
excluded from analysis.
Sensitivity analyses assessed additional 
ΔPM10 interactions with (average BMI)2 and 
ΔBMI. Furthermore, we estimated ΔPM10 
effects and interactions with average BMI, 
stratified by sex, by smoking status, by age, 
and by the presence or absence of a self­report 
of physician­diagnosed asthma. p­Values 
< 0.05 were interpreted as statistically sig­
nificant for both main effects and inter­
actions. Statistical analyses were performed 
using SAS, version 9.2 (SAS Institute Inc., 
Cary, NC, USA).
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Results
The baseline, follow­up, and change in 
charac teristics of study participants are 
shown in Table 1. SAPALDIA participants 
included in the present study were more 
likely than nonparticipants to be females and 
never­smokers, and less likely to be of lower 
social class or over weight (see Supplemental 
Material, Table S1). Average BMI was classi­
fied as normal for most participants (56.3%), 
whereas 32.8% were obese, and only 17.9% 
were underweight (Table 1). On average, 
participants in all BMI categories at baseline 
gained weight during follow­up.
Table 2 shows the mean annual decline 
for the different lung function parameters 
according to average BMI category. Except 
for FVC, the decline of lung function 
increased with decreasing average BMI.
The median PM10 concentration at fol­
low­up was 5.3 µg/m3 less than the median 
concentration at baseline, with an interquar­
tile range (IQR) for the change in PM10 of 
–4.2 to –7.6 µg/m3. The improvement in air 
quality was greater for participants living in 
urban areas compared with residents of the 
Alpine regions (Liu et al. 2007). As previously 
reported (Downs et al. 2007), a decrease in 
PM10 exposure during follow­up was associ­
ated with an attenuation of the age­related 
decline in FEV1, FEV1/FVC, and FEF25–75, 
but not FVC. The attenuation was stron­
gest for FEF25–75 (data not shown). Table 3 
presents the association between ΔPM10 
and lung function decline according to cat­
egories of average BMI, expressed as percent 
attenuation of mean annual decline in lung 
function (see Table 3 and Figure 1 for esti­
mates expressed as absolute excess decline). 
Statistically significant interactions between 
ΔPM10 and average BMI were observed for 
all lung function parameters except FEV1. 
Unexpectedly, improved air quality was 
associated with a significant acceleration 
in FVC decline among participants in the 
lowest average BMI category. In contrast, 
improved air quality was associated with 
greater reductions in the annual rates decline 
of FEF25–75, FEF25–75/FVC, and FEV1/
FVC among participants with low or normal 
average BMI, whereas there was little or no 
evidence of a beneficial effect of improved 
air quality on lung function decline among 
those who were overweight or obese (Table 3, 
Figure 1; see also Supplemental Material, 
Table S2). Thus, our findings suggest that 
beneficial effects of improved air quality on 
lung function parameters were greatest for 
participants with a low or normal BMI. The 
strongest associations between a 10­µg/m3 
decrease in PM10 and a reduction in lung 
function decline were estimated for the ratio 
FEF25–75/ FVC among those with low and 
normal average BMI (annual rate of decline 
reduced by approximately 30% and 22%, 
respectively) (Table 3).
Sensitivity analyses did not indicate inter­
actions of ΔPM10 with (average BMI)2 or 
ΔBMI, or differences in effect modification of 
associations between ΔPM10 and lung func­
tion decline by BMI according to either sex 
or smoking (never­ vs. ever­smokers) (data 
not shown). When the analysis was restricted 
to subjects ≥ 30 years of age, the associa­
tions were not materially altered (Table 3). 
Interestingly, the attenuating association of 
improved air quality on FEF25–75, FEF25–75/
FVC (see Supplemental Material, Figure S2), 
and FEV1/FVC decline was less dependent on 
BMI in the subgroup of asthmatics (Figure 2).
Discussion
This study suggests that attenuation of age­
related lung function decline due to improved 
air quality may be observable only in normal­
weight and underweight persons.
Table 1. Characteristics of study participants (n = 4,664) at baseline (SAPALDIA 1) and follow-up 
(SAPALDIA 2) and change in lung function, BMI, and individually assigned air quality estimates from 
SAPALDIA 1 to 2. 
Characteristic SAPALDIA 1 SAPALDIA 2 Change SAP1–SAP2
Female [n (%)] 2,518 (54) 2,518 (54)
Age (years) 41.3 ± 11.2 52.2 ± 11.2
Height (cm) 169.1 ± 8.8 168.7 ± 8.9
Weight (kg) 67.9 ± 12.5 73.5 ± 14.5
PM10 (µg/m3)
Median 25.7 20.7 –5.3
IQR 21.6 to 32.3 17.2 to 25.4 –7.6 to –4.2
FVC (mL) 4,487 ± 1,013 4,221 ± 1,014 –266 ± 423
FEV1 (mL) 3,541 ± 815 3,157 ± 809 –384 ± 314
FEF25–75 (mL/sec) 3,396 ± 1,200 2,624 ± 1,121 –772 ± 684
FEV1/FVC (%) 79.2 ± 7.4 74.8 ± 7.3 –4.4 ± 5.1
FEF25–75/FVC (%/sec) 76.8 ± 24.9 62.4 ± 23.1 –14.4 ± 17.4
BMI (kg/m2) 23.6 ± 3.6 25.7 ± 4.3 2.1 ± 2.2
Average BMI (kg/m2)
< 18.5 (n = 80) 17.9 ± 0.58
18.5–< 25 (n = 2,625) 22.3 ± 1.70
25–< 30 (n = 1,549) 27.0 ± 1.41
≥ 30 (n = 410) 32.8 ± 2.54
Smoking status (%)
Never 49.3 48.1
Former 20.5 29.0
Current 30.2 22.9
No. of pack-years for ever-smokers
Median 13.9 18.4
IQR 5.2–27.0 7.3–36
No. of cigarettes per day for current smokers
Median 20 15
IQR 10–25 6–20
Passive smoking during childhood (%) 54.0 —a
Workplace exposure to dust/gases/fumes (%) 30.0 26.8
Swiss nationality (%) 87.7 —a
Education level (%)b
Low 13.4 5.9
Intermediate 69.5 66.5
High 17.1 27.6
Increase in education levels between surveys (%) 17.7
Atopy in 1991 (%)c 21.9
Physician-diagnosed asthma 7.3 7.8
Area (%)
Basel 11.9 11.8
Wald 19.6 19.7
Davos 7.7 7.5
Lugano 14.1 14.2
Montana 9.7 9.6
Payerne 14.1 14.2
Aarau 15.3 15.3
Geneva 7.6 7.7
Values are mean ± SD unless otherwise indicated.
aMissing values were assessed only at baseline. bFor the assessment of socioeconomic stsatus the educational level 
at baseline and the change of educational level between the surveys was assessed. Low education corresponds to 
primary school level, intermediate to secondary, middle, or apprenticeship school, and high education corresponds 
to technical college or university. cAtopy assessed in 1991, by a skin prick test. Participants were classified as having 
atopy if they developed response to one or more of the eight inhalant allergens tested (cat, timothy grass, parietaria, 
birch, house-dust mite, Alternaria tenuis, Cladosporium herbarum, and dog).
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The presence of excess weight (as in over­
weight or obese persons) leads to a mechani­
cal stiffening of the respiratory system. The 
observed associations between respiratory 
system stiffening and decreased lung compli­
ance have been attributed to a combination of 
increased pulmonary blood volume, closure 
of dependent airways, or increased alveolar 
surface tension (Salome et al. 2010). Our lon­
gitudinal analysis provides novel evidence that 
the rate of age­related loss in FEF25–75 and 
FEF25–75/FVC is slower in obese adults than 
in normal­weight or underweight adults. This 
is consistent with the observation that the 
FEV1/FVC ratio is usually normal in obese 
persons (Salome et al. 2010).
Against this background, several scenarios 
could explain the observed modification of 
the association between change in PM10 and 
lung function decline by obesity.
First, a decrease in lung compliance due 
to weight increase could mask any improve­
ment in small airway function in response to 
reduced exposure to air pollution. In addi­
tion, chronic low­grade inflammation, which 
is associated with obesity, may limit beneficial 
effects of improved air quality on peripheral 
lung tissue. Air pollution exposure and mul­
tiple adipokines both have been associated 
with altered cell proliferation and airway or 
tissue remodeling (Anderson et al. 2013; 
Ferecatu et al. 2010; Medoff et al. 2009). 
The small airway epithelium is thought to 
play a particularly important role in airway 
obstruction and accelerated lung function 
decline in patients with chronic obstructive 
pulmonary disease (COPD) and asthma, and 
may contribute to the association of these 
respiratory diseases with chronic inflamma­
tion in response to exposure to particles from 
tobacco smoke and air pollution (Burgel 
2011). The airway remodeling processes 
induced by chronic inflammation are thought 
to differ between asthma and COPD patients. 
In COPD, remodeling of the small airways 
and lung parenchyma contributes to obstruc­
tions in air flow (Sköld 2010), whereas in 
asthma, airway obstruction may originate 
predominantly in the larger airways. The 
role of airway remodeling in modifying lung 
function response to improved air quality is 
supported by our previous finding of an inter­
action between ΔPM10 and polymorphisms 
in apoptosis­related gene (Imboden et al. 
2009), as well as by the fact that the observed 
interactions in this study were restricted to 
average BMI, which is likely to reflect chronic 
effects in ΔBMI.
Second, the results may be interpreted as 
obesity reducing associations between lung 
function decline and reduction in air pollu­
tion. This adverse effect is unlikely direct or 
causal. Rather, it reflects the obesity paradox 
in which overweight persons of advanced age 
have a better prognosis for various chronic 
conditions, including pulmonary disease 
(Blum et al. 2011). Although the obesity 
paradox generally applies to patients rather 
than to population­based cohorts, we can­
not exclude the possibility that excess weight, 
particularly in the elderly, may reflect a 
general state of well­being, and thus poten­
tially reduced susceptibility to inflammatory 
agents. It is possible that because the rate of 
age­related decline is slower in obese partici­
pants, it is not possible to observe a benefit of 
reduced air pollution on the decline with age.
Unfortunately, in SAPALDIA we had only 
self­reported weights at baseline, which might 
be a source of bias due to misclassi fication. 
However, all individuals were weighed at the 
follow­up assessment, and most individuals 
did not show unexpectedly large weight dif­
ferences between the two studies. Moreover, 
weight reporting errors are unlikely to be cor­
related with air pollution levels and changes. 
The observation that the interaction between 
ΔPM10 and average BMI appeared to be 
restricted to nonasthmatics is an exploratory 
finding and needs confirmation. Independent 
data on the association of air pollution 
with lung function and obesity in specific 
population subgroups is generally sparse. 
Table 2. Adjusted mean annual rates of change (95% CI) for the different lung function variables according to average BMI.
Outcome
BMI (kg/m2)
< 18.5 18.5–< 25 25–< 30 ≥ 30
∆FEV1/years (mL/year) –35.1 (–45.4, –24.8) –35.9 (–45.8, –6.0) –35.7 (–45.6, –25.7) –33.9 (–44.1, –23.8)
∆FVC/years (mL/year) –15.0 (–27.2, –2.9) –22.0 (–33.6, –10.5) –27.9 (–39.5, –16.4) –37.0 (–44.4, –20.6)
∆FEV1/FVC/years (%/year) –0.6 (–0.7, –0.4) –0.5 (–0.6, –0.3) –0.3 (–0.5, –0.3) –0.2 (–0.4, –0.1)
∆FEF25–75/years (mL/sec/year) –81.9 (–102, –61.6) –75.7 (–95.0, –56.5) –67.0 (–86.3, –47.7) 53.9 (–73.8, –33.9)
∆FEF25–75/FVC/years (%/sec/year) –1.8 (–2.3, –1.3) –1.5 (–1.9, –1.0) –1.2 (–1.6, –0.7) –0.8 (–1.3, –0.3)
Estimates are derived from models adjusted for PM10 baseline, BMI average, BMI average squared, BMI difference, age, age squared, height, smoking status, pack-years (baseline 
and follow-up), cigarettes per day, passive smoking during childhood, educational level, workplace exposure, presence of atopy, nationality, season of examination.
To compute covariate-adjusted means of lung function decline for the different categories of average BMI, all covariates other than average BMI were centered at their mean values 
in the sample (n = 4,664). The variable BMI average was successively centered at its mean values in the four categories defined by the cutoffs 18.5 kg/m2, 25 kg/m2, and 30 kg/m2. In this 
way, the adjusted means of interest were provided by the intercept estimates. Negative values indicate decline in lung function between baseline and follow-up examination.
Table 3. Adjusted estimates of the association between change in PM10 during follow-up and the annual rates of decline of the different lung function variables 
(95% CI), according to average BMI and attenuation of decline in lung function parameters associated with a 10-μg/m3 decrease in PM10, expressed as a per-
centage of the mean annual decline for different values of average BMI in all subjects (n = 4,664).
Outcome Estimate
BMI (kg/m2) p-Value for 
interaction< 18.5 18.5–< 25 25–< 30 ≥ 30
∆FEV1/years (mL/year) ∆PM10 effect estimate –2.38 (–6.55, 1.80) –2.37 (–5.50, 0.75) –2.37 (–6.11, 1.37) –2.37 (–8.40, 3.67) 0.99
Attenuation by ∆PM10 (%) 6.8 6.6 6.6 7.0
∆FVC/years (mL/year) ∆PM10 effect estimate 5.64 (0.07, 11.2) 2.10 (–2.07, 6.27) –1.78 (–6.77, 3.22) –6.42 (–14.5, 1.65) 0.027
Attenuation by ∆PM10 (%) –37.6 –9.5 6.4 19.8
FEV1/FVC/years (%/year) ∆PM10 effect estimate –0.14 (–0.21, –0.06) –0.08 (–0.13, –0.02) –0.02 (–0.08, 0.05) 0.06 (–0.04, 0.16) 0.005
Attenuation by ∆PM10 (%) 22.5 15.6 5.0 –30.5
∆FEF25–75/years (mL/sec/year) ∆PM10 effect estimate –21.6 (–31.2, –12.0) –14.0 (–21.1, –6.8) –5.6 (–14.2, 3.0) 4.4 (–9.5, 18.2) 0.006
Attenuation by ∆PM10 (%) 26.4 18.5 8.4 –8.1
∆FEF25–75/FVC/years (%/sec/year) ∆PM10 effect estimate –0.53 (–0.78, –0.29) –0.33 (–0.51, –0.14) –0.10 (–0.32, 0.12) 0.16 (–0.19, 0.52) 0.004
Attenuation by ∆PM10 (%) 29.6 21.8 8.6 –20.6
Effect estimates for a 10-µg/m3 change in PM10 were computed for the mean BMI values of the respective categories. Estimates are adjusted for PM10 baseline, BMI average, BMI 
average squared, BMI difference, age, age squared, height, smoking status, pack-years (baseline and follow-up), cigarettes per day, parental smoking, educational level, workplace 
exposure, presence of atopy, nationality, seasonality. Negative estimates indicate a reduction in age-related lung function decline in association with a decrease in PM10. Positive 
 values in attenuation of decline in lung function indicate a beneficial effect of declining PM10 levels (% of mean decline of lung function).
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A longitudinal study among persons with 
asthma found that the adverse effect of weight 
gain on lung function might be greater for 
subjects with asthma than for subjects without 
airflow obstruction (Marcon et al. 2009). In a 
cross­sectional study of asthma patients, par­
ticipants who were obese had lower FEV1 than 
their normal­weight counterparts (Pakhale 
et al. 2010). In a randomized trial of supervised 
weight loss in 38 obese subjects with asthma, 
asthma symptoms decreased and lung function 
improved following weight loss in the treat­
ment group (Stenius­Aarniala et al. 2000). 
However, none of the studies above evaluated 
modification of associations between body 
weight and lung function by air pollution.
A major strength of the present study is 
its large sample size and the availability of 
longitudinal data for air pollution expo­
sure, BMI, and lung function after 10 years 
of follow­up. Lung function measurements 
were subjected to stringent quality control 
and conducted by identical devices in all 
individuals at baseline and follow­up (Künzli 
et al. 1995, 2005). In previous analyses, we 
have found associations with air pollution 
and their modification by genetic factors to 
be strongest for mid­flow parameters (i.e., 
FEF25–75 and FEF25–75/FVC) and consider 
the availability of these parameters to be of 
great importance (Chinn et al. 2005). Mid­
flow parameters are more sensitive than 
FEV1, and their association with PM10 is 
stronger (Downs et al. 2007; Imboden et al. 
2009). They are most commonly used to 
indicate small airway diseases. Moreover, 
the authors of a study on FEF25–75 and its 
FVC ratio in families with severe, early­onset 
COPD reported that these parameters had 
a high heritability, and suggested that they 
may be important intermediate phenotypes 
to consider in genetic linkage and associa­
tion studies of COPD (DeMeo et al. 2004). 
Further, it has been shown that small airway 
inflammatory reactions that result from PM 
exposures usually occur before the develop­
ment of tissue destruction and fibrosis and 
clinically detectable COPD (Niewoehner 
et al. 1974; Saetta et al. 2001).
Conclusion
The relationship between obesity, lung func­
tion, and air pollution is highly complex. 
Longitudinal research with additional infor­
mation on visceral fat and markers of local 
and systemic inflammation (Parameswaran 
et al. 2006; Steele et al. 2009) is needed to 
clarify whether the lung function of obese 
persons does not benefit from improved air 
quality, or whether a benefit in the small air­
ways is merely masked.
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Figure 1. Estimated reduction in average annual lung function decline (95% CI) associated with a 10-µg/m3 
decrease in PM10 during follow-up for FEV1/FVC (A) and FEF25–75 (B) according to average BMI. Estimates 
are adjusted for PM10 baseline, BMI average, BMI average squared, BMI difference, age, age squared, 
height, smoking status, pack-years (baseline and follow-up), cigarettes per day, parental smoking, educa-
tional level, workplace exposure, presence of atopy, nationality, seasonality. Negative estimates indicate 
a reduction in age-related lung function decline in association with a decrease in PM10. Average BMI 
categories are underweight (< 18.5 kg/m2), normal weight (18.5–< 25), overweight (25–< 30), and obese 
(≥ 30 kg/m2).
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Figure 2. Comparison of the associations between change in PM10 during follow-up and the annual 
changes in the lung function parameters FEV1/FVC and FEF25–75 in subjects with and without physician-
diagnosed asthma ever, for different values of average BMI (kg/m2). Negative estimates indicate a reduc-
tion in age-related lung function decline in association with a decrease in PM10. 
< 18.5 18.5– < 25 25– < 30 18.5– < 25 25– < 30≥ 30 < 18.5 ≥ 30
40
20
0
–20
–40
–60
–80
–100
–120
0.4
0.3
0.2
0.1
0
–0.1
–0.2
–0.3
–0.4
–0.5
–0.6
Average BMI Average BMI
M
ea
n 
ch
an
ge
 in
 a
nn
ua
l r
at
e 
of
 d
ec
lin
e 
of
FE
V 1
/F
VC
 (%
) f
or
 1
0-
µg
/m
3  d
ec
re
as
e 
in
 P
M
10
M
ea
n 
ch
an
ge
 in
 a
nn
ua
l r
at
e 
of
 d
ec
lin
e 
of
FE
F 2
5–
75
 (m
L/
se
c)
 fo
r 1
0-
µg
/m
3  d
ec
re
as
e 
in
 P
M
10
Non-asthmatic
Asthmatic
BMI and benefits of reduced air pollution
Environmental Health Perspectives • volume 121 | number 9 | September 2013 1039
RefeRences
Ackermann-Liebrich U, Kuna-Dibbert B, Probst-Hensch NM, 
Schindler  C, Felber Dietrich D, Stutz EZ, et  al. 2005. 
Follow-up of the Swiss Cohort Study on Air Pollution and 
Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods 
and characterization of participants. Soz Praventivmed 
50:245–263.
Ackermann-Liebrich U, Leuenberger P, Schwartz J, Schindler C, 
Monn C, Bolognini G, et al. 1997. Lung function and long 
term exposure to air pollutants in Switzerland. Study on Air 
Pollution and Lung Diseases in Adults (SAPALDIA) team. 
Am J Respir Crit Care Med 155:122–129.
Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, 
Sorensen M, et al. 2011. Chronic obstructive pulmonary 
disease and long-term exposure to traffic-related air pollu-
tion: a cohort study. Am J Respir Crit Care Med 183:455–461.
Anderson RF, Favarato G, Atkinson RW. 2013. Long-term expo-
sure to air pollution and the incidence of asthma: meta-
analysis of cohort studies. Air Qual Atmos Health 6(1):47–56; 
doi:10.1007/s11869-011-0144-5 [Online 7 April 2011].
ATS (American Thoracic Society). 1991. Lung function test-
ing: selection of reference values and interpretative 
 strategies. American Thoracic Society. Am Rev Respir Dis 
144:1202–1218.
Blum A, Simsolo C, Sirchan R, Haiek S. 2011. “Obesity para-
dox” in chronic obstructive pulmonary disease. Isr Med 
Assoc J 13:672–675.
Breton CV, Salam MT, Vora H, Gauderman WJ, Gilliland FD. 
2011. Genetic variation in the glutathione synthesis path-
way, air pollution, and children’s lung function growth. 
Am J Respir Crit Care Med 183:243–248.
Burgel PR. 2011. The role of small airways in obstructive 
a i r w a y  d i s e a s e s .  E u r  R e s p i r  R e v  2 0 : 2 3 – 3 3 ; 
doi:10.1183/09059180.00010410.
Chen C, Arjomandi M, Tager IB, Holland N, Balmes JR. 2007. 
Effects of antioxidant enzyme polymorphisms on ozone-
induced lung function changes. Eur Respir J 30:677–683.
Chinn S, Downs SH, Anto JM, Gerbase MW, Leynaert B, 
de Marco R, et al. 2006. Incidence of asthma and net 
change in symptoms in relation to changes in obesity. Eur 
Respir J 28:763–771.
Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, 
Anto JM, et al. 2005. Smoking cessation, lung function, and 
weight gain: a follow-up study. Lancet 365:1629–1635. 
DeMeo DL, Carey VJ, Chapman HA, Reilly JJ, Ginns LC, 
Speizer FE, et al. 2004. Familial aggregation of FEF25–75 and 
FEF25–75/FVC in families with severe, early onset COPD. 
Thorax 59:396–400.
Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, 
Brutsche MH, et al. 2007. Reduced exposure to PM10 and 
attenuated age-related decline in lung function. N Engl J 
Med 357:2338–2347.
Ferecatu I, Borot MC, Bossard C, Leroux M, Boggetto N, 
Marano F, et al. 2010. Polycyclic aromatic hydrocarbon 
components contribute to the mitochondria-antiapoptotic 
effect of fine particulate matter on human bronchial epi-
thelial cells via the aryl hydrocarbon receptor. Part Fibre 
Toxicol 7:18; doi:10.1186/1743-8977-7-18.
Franssen FM, O’Donnell DE, Goossens GH, Blaak EE, Schols AM. 
2008. Obesity and the lung: 5. Obesity and COPD. Thorax 
63:1110–1117.
Gotz AA, Rozman J, Rodel HG, Fuchs H, Gailus-Durner V, Hrabe 
de Angelis M, et al. 2011. Comparison of particle-exposure 
triggered pulmonary and systemic inflammation in mice 
fed with three different diets. Part Fibre Toxicol 8:30; 
doi:10.1186/1743-8977-8-30.
Hickson DA, Liu J, Bidulescu A, Burchfiel CM, Taylor HA, Petrini 
MF. 2011. Pericardial fat is associated with impaired 
lung function and a restrictive lung pattern in adults: the 
Jackson Heart Study. Chest 140(6):1567–1573; doi:10.1378/
chest.11-0258.
Hogg JC, van Eeden S. 2009. Pulmonary and systemic response 
to atmospheric pollution. Respirology 14:336–346.
Imboden M, Schwartz J, Schindler C, Curjuric I, Berger W, 
Liu SL, et al. 2009. Decreased PM10 exposure attenuates 
age-related lung function decline: genetic variants in p53, 
p21, and CCND1 modify this effect. Environ Health Perspect 
117:1420–1427; doi:10.1289/ehp.0800430.
Jones DP, Camargo CA Jr, Speizer FE, Barr RG. 2007. Prospective 
study of short stature and newly diagnosed asthma in 
women. J Asthma 44:291–295.
Künzli N, Ackermann-Liebrich U, Keller R, Perruchoud AP, 
Schindler C. 1995. Variability of FVC and FEV1 due to techni-
cian, team, device and subject in an eight centre study: 
three quality control studies in SAPALDIA. Swiss Study 
on Air Pollution and Lung Disease in Adults. Eur Respir J 
8:371–376.
Künzli N, Kuna-Dibbert B, Keidel D, Keller R, Brandli O, Schindler 
C, et al. 2005. Longitudinal validity of  spirometers–a chal-
lenge in longitudinal studies. Swiss Med Wkly 135:503–508.
Lecube A, Sampol G, Munoz X, Ferrer R, Hernandez C, Simo R. 
2011. TNF-α system and lung function impairment in 
 obesity. Cytokine 54:121–124.
Liu LJ, Curjuric I, Keidel D, Heldstab J, Künzli N, Bayer-
Oglesby L, et al. 2007. Characterization of source-specific 
air pollution exposure for a large population-based Swiss 
cohort (SAPALDIA). Environ Health Perspect 115:1638–1645; 
doi:10.1289/ehp.10177.
Madrigano J, Baccarelli A, Wright RO, Suh H, Sparrow D, 
Vokonas PS, et  al. 2009. Air pollution, obesity, genes 
and cellular adhesion molecules. Occup Environ Med 
67:312–317.
Marcon A, Corsico A, Cazzoletti L, Bugiani M, Accordini S, 
Almar E, et al. 2009. Body mass index, weight gain, and 
other determinants of lung function decline in adult 
asthma. J Allergy Clin Immunol 123:1069–1074. 
Margretardottir OB, Thorleifsson SJ, Gudmundsson G, 
Olafsson I, Benediktsdottir B, Janson C, et  al. 2009. 
Hypertension, systemic inflammation and body weight in 
relation to lung function impairment—an epidemiological 
study. COPD 6:250–255.
Martin BW, Ackermann-Liebrich U, Leuenberger P, Künzli N, 
Stutz EZ, Keller R, et al. 1997. SAPALDIA: methods and 
participation in the cross-sectional part of the Swiss 
Study on Air Pollution and Lung Disease in Adults. Soz 
Praventivmed 42:67–84.
McClean KM, Kee F, Young IS, Elborn JS. 2008. Obesity and the 
lung: 1. Epidemiology. Thorax 63:649–654.
Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, 
Raher MJ, et al. 2009. Adiponectin deficiency increases 
allergic airway inflammation and pulmonary vascular 
remodeling. Am J Respir Cell Mol Biol 41:397–406.
Niewoehner DE, Kleinerman J, Rice DB. 1974. Pathologic 
changes in the peripheral airways of young cigarette 
smokers. N Engl J Med 291:755–758.
Pakhale S, Doucette S, Vandemheen K, Boulet LP, McIvor RA, 
Fitzgerald JM, et al. 2010. A comparison of obese and non-
obese people with asthma: exploring an asthma-obesity 
interaction. Chest 137:1316–1323.
Parameswaran K, Todd DC, Soth M. 2006. Altered respiratory 
physiology in obesity. Can Respir J 13:203–210.
Probst-Hensch NM. 2010. Chronic age-related diseases share 
risk factors: do they share pathophysiological mechanisms 
and why does that matter? Swiss Med Wkly 140:w13072; 
doi:10.4414/smw.2010.13072.
Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. 2001. 
Cellular and structural bases of chronic obstructive pul-
monary disease. Am J Respir Crit Care Med 163:1304–1309.
Salome CM, King GG, Berend N. 2010. Physiology of obesity 
and effects on lung function. J Appl Physiol 108:206–211.
Sinden NJ, Stockley RA. 2010. Systemic inflammation and 
comorbidity in COPD: a result of “overspill” of inflamma-
tory mediators from the lungs? Review of the evidence. 
Thorax 65:930–936.
Sköld CM. 2010. Remodeling in asthma and COPD–differences 
and similarities. Clin Respir J 4(suppl 1):20–27.
Steele RM, Finucane FM, Griffin SJ, Wareham NJ, Ekelund U. 
2009. Obesity is associated with altered lung function 
independently of physical activity and fitness. Obesity 
(Silver Spring) 17:578–584.
Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, 
Ylikahri M, Mustajoki P. 2000. Immediate and long term 
effects of weight reduction in obese people with asthma: 
randomised controlled study. BMJ 320:827–832.
Thyagarajan B, Jacobs DR Jr, Smith LJ, Kalhan R, Gross MD, 
Sood A. 2010. Serum adiponectin is positively associated 
with lung function in young adults, independent of obesity: 
the CARDIA study. Respir Res 11:176; doi:10.1186/1465-
9921-11-176.
Tkacova R. 2010. Systemic inflammation in chronic obstruc-
tive pulmonary disease: may adipose tissue play a 
role? Review of the literature and future perspectives. 
Mediators Inflamm 2010:585989; doi:10.1155/2010/585989.
Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, 
Lindgren P, et al. 1998. Effect of weight gain on pulmonary 
function after smoking cessation in the lung health study. 
Am J Respir Crit Care Med 157:866–872.
